206 related articles for article (PubMed ID: 16409192)
1. The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in mice.
Winkler B; Hufnagl K; Spittler A; Ploder M; Kállay E; Vrtala S; Valenta R; Kundi M; Renz H; Wiedermann U
Allergy; 2006 Feb; 61(2):173-80. PubMed ID: 16409192
[TBL] [Abstract][Full Text] [Related]
2. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
[TBL] [Abstract][Full Text] [Related]
3. Airway inflammation induced after allergic poly-sensitization can be prevented by mucosal but not by systemic administration of poly-peptides.
Hufnagl K; Focke M; Gruber F; Hufnagl P; Loupal G; Scheiner O; Wiedermann U
Clin Exp Allergy; 2008 Jul; 38(7):1192-202. PubMed ID: 18462454
[TBL] [Abstract][Full Text] [Related]
4. A recombinant allergen chimer as novel mucosal vaccine candidate for prevention of multi-sensitivities.
Wild C; Wallner M; Hufnagl K; Fuchs H; Hoffmann-Sommergruber K; Breiteneder H; Scheiner O; Ferreira F; Wiedermann U
Allergy; 2007 Jan; 62(1):33-41. PubMed ID: 17156339
[TBL] [Abstract][Full Text] [Related]
5. Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice.
Wiedermann U; Herz U; Baier K; Vrtala S; Neuhaus-Steinmetz U; Bohle B; Dekan G; Renz H; Ebner C; Valenta R; Kraft D
Int Arch Allergy Immunol; 2001 Sep; 126(1):68-77. PubMed ID: 11641608
[TBL] [Abstract][Full Text] [Related]
6. Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice.
Wagner A; Förster-Waldl E; Garner-Spitzer E; Schabussova I; Kundi M; Pollak A; Scheiner O; Joachim A; Wiedermann U
Int J Parasitol; 2009 Mar; 39(4):465-72. PubMed ID: 18938169
[TBL] [Abstract][Full Text] [Related]
7. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
[TBL] [Abstract][Full Text] [Related]
8. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
Savolainen J; Jacobsen L; Valovirta E
Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
[TBL] [Abstract][Full Text] [Related]
9. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization with a dominant T-cell epitope peptide of a major allergen of olive pollen prevents mice from sensitization to the whole allergen.
Marazuela EG; Rodríguez R; Fernández-García H; García MS; Villalba M; Batanero E
Mol Immunol; 2008 Jan; 45(2):438-45. PubMed ID: 17662454
[TBL] [Abstract][Full Text] [Related]
11. Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.
van Puijvelde GH; van Es T; van Wanrooij EJ; Habets KL; de Vos P; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2677-83. PubMed ID: 17901374
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
[TBL] [Abstract][Full Text] [Related]
13. Expression of the Foxp3 gene in spleen mononuclear cells of a mouse model with allergic rhinitis.
Han D; Xi L; Fan E; Li Y; Zhang L
ORL J Otorhinolaryngol Relat Spec; 2009; 71(6):317-22. PubMed ID: 20029241
[TBL] [Abstract][Full Text] [Related]
14. Intranasal treatment with ovalbumin but not the major T cell epitope ovalbumin 323-339 generates interleukin-10 secreting T cells and results in the induction of allergen systemic tolerance.
Barbey C; Donatelli-Dufour N; Batard P; Corradin G; Spertini F
Clin Exp Allergy; 2004 Apr; 34(4):654-62. PubMed ID: 15080822
[TBL] [Abstract][Full Text] [Related]
15. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
[TBL] [Abstract][Full Text] [Related]
16. Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens.
Jahn-Schmid B; Radakovics A; Lüttkopf D; Scheurer S; Vieths S; Ebner C; Bohle B
J Allergy Clin Immunol; 2005 Jul; 116(1):213-9. PubMed ID: 15990797
[TBL] [Abstract][Full Text] [Related]
17. Immune regulation by CD4+CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls.
Thunberg S; Akdis M; Akdis CA; Grönneberg R; Malmström V; Trollmo C; van Hage M; Gafvelin G
Clin Exp Allergy; 2007 Aug; 37(8):1127-36. PubMed ID: 17651141
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharides modulate allergen-specific immune regulation in a murine model of mucosal tolerance induction.
Gerhold K; Avagyan A; Reichert E; Blumchen K; Wahn U; Hamelmann E
Int Arch Allergy Immunol; 2008; 147(1):25-34. PubMed ID: 18446050
[TBL] [Abstract][Full Text] [Related]
19. Multiple T cell epitope peptides suppress allergic responses in an egg allergy mouse model by the elicitation of forkhead box transcription factor 3- and transforming growth factor-beta-associated mechanisms.
Yang M; Yang C; Mine Y
Clin Exp Allergy; 2010 Apr; 40(4):668-78. PubMed ID: 20082619
[TBL] [Abstract][Full Text] [Related]
20. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
